Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2637647rdf:typepubmed:Citationlld:pubmed
pubmed-article:2637647lifeskim:mentionsumls-concept:C0150369lld:lifeskim
pubmed-article:2637647lifeskim:mentionsumls-concept:C0003290lld:lifeskim
pubmed-article:2637647lifeskim:mentionsumls-concept:C0041056lld:lifeskim
pubmed-article:2637647lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:2637647lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:2637647pubmed:issue5lld:pubmed
pubmed-article:2637647pubmed:dateCreated1990-7-16lld:pubmed
pubmed-article:2637647pubmed:abstractTextNow it is not possible to choose an efficacious dosage of trimipramine when measuring serum drug concentrations. At once those measurement are useful to assure the long term surveillance of the treatment. That's why we propose to define a personal therapeutic interval that allows to limit the area in which the drug concentrations must be found.lld:pubmed
pubmed-article:2637647pubmed:languagefrelld:pubmed
pubmed-article:2637647pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2637647pubmed:citationSubsetIMlld:pubmed
pubmed-article:2637647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2637647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2637647pubmed:statusMEDLINElld:pubmed
pubmed-article:2637647pubmed:issn0003-4509lld:pubmed
pubmed-article:2637647pubmed:authorpubmed-author:HenniauxMMlld:pubmed
pubmed-article:2637647pubmed:authorpubmed-author:ForzyGGlld:pubmed
pubmed-article:2637647pubmed:authorpubmed-author:ConvainLLlld:pubmed
pubmed-article:2637647pubmed:authorpubmed-author:VittuCClld:pubmed
pubmed-article:2637647pubmed:issnTypePrintlld:pubmed
pubmed-article:2637647pubmed:volume47lld:pubmed
pubmed-article:2637647pubmed:ownerNLMlld:pubmed
pubmed-article:2637647pubmed:authorsCompleteYlld:pubmed
pubmed-article:2637647pubmed:pagination276-82lld:pubmed
pubmed-article:2637647pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:meshHeadingpubmed-meshheading:2637647-...lld:pubmed
pubmed-article:2637647pubmed:year1989lld:pubmed
pubmed-article:2637647pubmed:articleTitle[Tricyclic antidepressants and therapeutic monitoring. An experience with trimipramine].lld:pubmed
pubmed-article:2637647pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2637647pubmed:publicationTypeEnglish Abstractlld:pubmed